Similar articles

• Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.

  Meyers C, Arimura A, Gordin A, Fernandez-Durango R, Coy DH, Schally AV, Drouin J, Ferland L, Beaulieu M, Labrie F. Meyers C, et al. Biochem Biophys Res Commun. 1977 Jan 24;74(2):630-6. doi: 10.1016/0006-291x(77)90349-7. Biochem Biophys Res Commun. 1977. PMID: 836315 No abstract available.
• Somatostatin: analogs with selected biological activities.

  Brown M, Rivier J, Vale W. Brown M, et al. Science. 1977 Jun 24;196(4297):1467-9. doi: 10.1126/science.867045. Science. 1977. PMID: 867045
• Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.

  Karashima T, Cai RZ, Schally AV. Karashima T, et al. Life Sci. 1987 Aug 24;41(8):1011-9. doi: 10.1016/0024-3205(87)90690-4. Life Sci. 1987. PMID: 2886886
• Somatostatin.

  Vale W, Brazeau P, Rivier C, Brown M, Boss B, Rivier J, Burgus R, Ling N, Guillemin R. Vale W, et al. Recent Prog Horm Res. 1975;31:365-97. doi: 10.1016/b978-0-12-571131-9.50014-1. Recent Prog Horm Res. 1975. PMID: 1105719 Review. No abstract available.
• Somatostatin, basic and clinical studies. A review.

  Schally AV, Meyers CA. Schally AV, et al. Mater Med Pol. 1980 Jan-Jun;12(1-2):28-32. Mater Med Pol. 1980. PMID: 6120265 Review. No abstract available.